共 50 条
- [1] Fulvestrant in postmenopausal women with metastatic breast cancer progressing on prior endocrine therapy-updated results from an expanded access programmeANNALS OF ONCOLOGY, 2004, 15 : 36 - 36Petruzelka, L.Zimovjanova, M.Konopasek, B.Mares, P.Dlouha, Z.
- [2] Fulvestrant in postmenopausal women with metastatic breast cancer progressing on prior endocrine therapy - results from an expanded access programmeEJC SUPPLEMENTS, 2004, 2 (03): : 132 - 133Petruzelka, L.Zimovjanova, M.
- [6] Endocrine response after prior treatment with fulvestrant (Fasiodex®) in postmenopausal women with advanced breast cancerEUROPEAN JOURNAL OF CANCER, 2002, 38 : S98 - S99Cheung, KRobertson, JFRScott, NOwers, R
- [7] Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatmentJOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (16) : 3396 - 3403Howell, ARobertson, JFRAlbano, JQAschermannova, AMauriac, LKleeberg, URVergote, IErikstein, BWebster, AMorris, C
- [8] Double-blind, Randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: Results of a North American trialJOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (16) : 3386 - 3395Osborne, CKPippen, JJones, SEParker, LMEllis, MCome, SGertler, SZMay, JTBurton, GDimery, IWebster, AMorris, CElledge, RBuzdar, A
- [9] Fulvestrant is an effective and well-tolerated endocrine therapy for postmenopausal women with advanced breast cancer: results from clinical trialsBritish Journal of Cancer, 2004, 90 : S11 - S14I VergoteJ F R Robertson